Ebola hemorrhagic fever
MONDO:0005737A viral hemorrhagic fever that is caused by the Ebola virus, which is transmitted by contact with infected animals or humans; it is characterized by high fever, unexplained bleeding, and a high mortality rate.
Also known as: EHF, Ebola, Ebola fever, Ebola virus disease, Ebolavirus caused disease or disorder, Ebolavirus disease or disorder, Ebolavirus infectious disease
25 clinical trials for this condition and its sub-types, 21 tagged with Ebola hemorrhagic fever itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New sudan virus vaccine enters first human tests
Vaccine Recruiting nowThis early-stage study tests a new vaccine designed to prevent Sudan virus disease, a severe illness similar to Ebola. About 112 healthy adults aged 18-50 will receive either the vaccine or a placebo to check for side effects and measure immune responses. The goal is to see if th…
Phase 1 • Sponsor: International AIDS Vaccine Initiative • Aim: Vaccine
Last updated Sep 21, 2026 20:00 UTC
-
Can an mRNA vaccine stop a rare ebola strain?
Vaccine Recruiting nowThis early-stage trial is testing an experimental mRNA vaccine called mRNA-1469 to see if it is safe and can trigger an immune response against Ebola-Bundibugyo virus disease. Healthy adults aged 18 to 65 will receive either the vaccine or a placebo. The study focuses on safety a…
Phase 1 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Sep 12, 2026 00:00 UTC
-
Supercharged donor cells take on viruses after transplant
Disease control Recruiting nowThis study tests whether specially grown donor immune cells (viral-specific T-cells) can safely treat viral infections that often occur after a stem cell transplant. These infections can be serious and sometimes don't respond to standard antiviral drugs. The approach aims to boos…
Phase 1/2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can donor cells stop viruses after transplant?
Disease control Recruiting nowThis study tests whether giving patients donor-derived immune cells (VSTs) on a regular schedule can prevent dangerous viral infections after a stem cell transplant. 180 participants will be randomly assigned to receive VSTs either on a fixed schedule or only when a virus is dete…
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Ebola antibody cocktail made available in emergency outbreak
Disease control Expanded accessThis program provides emergency access to REGN-EB3, a combination of three antibodies, for people with confirmed Ebola virus disease. It is available to both adults and children in Ebola-affected regions, including pregnant women. The goal is to offer a potential treatment option…
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC